Molecular Carcinogenesis

Cover image for Vol. 53 Issue 9

Edited By: John DiGiovanni

Impact Factor: 4.77

ISI Journal Citation Reports © Ranking: 2013: 43/202 (Oncology); 62/291 (Biochemistry & Molecular Biology)

Online ISSN: 1098-2744


Author Guidelines


NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.

Permission Request Form


Author Guidelines


Online Submission and Peer Review


Manuscript Submission

Submit all new manuscripts online at ScholarOne (formerly known as Manuscript Central).

Launch your web browser and go to ScholarOne (formerly known as Manuscript Central). Check for an existing account. If you are submitting for the first time, and you do not have an existing account, create a new account. Follow all instructions.

At the end of a successful submission, a confirmation screen with manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact the editorial office at: mc@wiley.com .

Submit manuscript and all figures as individual files. Please do not mail paper copies of your manuscript.

RAPID REVIEW OF MANUSCRIPTS SUBMITTED PREVIOUSLY TO ANOTHER JOURNAL:

As stated in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” ( http://www.icmje.org ; Updated February 2006): “ If the manuscript has been submitted previously to another journal, it is helpful to include the previous editor’s and reviewers’ comments with the submitted manuscript, along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications and doing so may expedite the review process.”

For manuscripts previously submitted to other journals with impact factor more than 6, if authors include previous editor’s and reviewers’ comments along with their responses, Molecular Carcinogenesis will guarantee a rapid (within a week) in-house assessment, with three possible outcomes:

a) Acceptance or acceptance with minor changes (no additional external reviews needed);
b) Rejection;
c) Additional external review needed; in this case the authors will have the possibility of accepting the additional external review or withdrawing the manuscript.

Editorial office contact information:
Molecular Carcinogenesis Editorial Receiving Office
Attn: Rebecca Strauss
John Wiley & Sons, Inc.
111 River Street, 8th Floor
Hoboken, NJ 07030
Phone: 201-748-6930
E-mail: mc@wiley.com

Manuscript Preparation

Molecular Carcinogenesis does not accept unsolicited Working Hypotheses, Emerging Technologies, or In Perspective Reviews. Please do not submit any of these types of articles unless you have been specifically invited to do so.

Brief communications should not exceed 2,500 words (this does not include the abstract and title.) They can report preliminary data or ongoing work that does not warrant a full-length article. These communications must be complete manuscripts in which the traditional sections of the research paper may be combined. Include a complete reference list.

Research papers should contain the following sections: title page, abstract, introduction, materials and methods, results, discussion, acknowledgments (optional), references, tables, and figure legends. Use generic names of drugs and give manufacturer, city, and state or country of all trademarked equipment mentioned in the text.

Working Hypothesis is a forum for presenting ideas for further experimentation. Each Working Hypothesis is the author's personal viewpoint, based either on the author's own work or on the published literature. Each should be no longer than 20 double-spaced pages and contain no more thn 20 references and two figures.

Title page. Give a descriptive title with no abbreviations. Provide first and last names of each author and department and institutional affiliations. Give full address, telephone, and telefax of corresponding author. On the second page, acknowledge grant support and provide definitions for all abbreviations used, an abbreviated title, and three to five key words or terms not used in the article title, chosen as far as possible from the National Library of Medicine Medical Subject Headings . Avoid nonstandard abbreviations; do not abbreviate single words (see "Conventions and Nomenclature" for acceptable reporting methods and abbreviations).

Abstract. Limit the abstract to a single paragraph of not more than 250 words. It must describe the work and include the purpose, a brief statement of methods, and the results. Avoid statements such as "methods will be described" or "other data will be presented." Working Hypotheses do not have abstracts.

Search Engine Optimization: Driving usage and readership is critically important to raising the visibility of your published research. One of the key factors in sustaining long-term usage is through search engine optimization (SEO). Below is a list of suggested ways of maximizing your SEO.

1.
Make sure your article title is SEO-friendly. It should be descriptive, and it must include a key phrase from your topic. Key words should appear within the title’s first 65 characters.
2.
Provide up to five topic-specific key words or phrases in the keyword field.
3.
Be sure your key words and phrases appear in your abstract several times, but don’t go overboard or the search engine may kick you out.
4.
When referencing authors, be consistent. Use their names as they generally appear in past online publications.
5.
When appropriate, use your key words in article section headings. Remember: They can’t read it if they can’t find it! For more detailed information on SEO, including helpful examples, go to http://authorservices.wiley.com/bauthor/seo.asp.

References.The accuracy of references is the responsibility of the authors. Only published papers and those in press should be included in the reference list. Unpublished data and submitted manuscripts must be cited parenthetically within the text. Any personal communication and its date should be cited within the text; permission in writing from the communicator is required to publish the information. References should be prepared in the citation-sequence style described in the Council of Biology Editors Style Manual (6th edition, Cambridge University Press). References should be numbered in order of their first mention in the text and cited within square brackets on the line. In the reference list, list all authors if there are six or fewer; list the first three and et al. if there are seven or more. Index Medicus abbreviations should be used for journal titles; the titles of unindexed journals should be spelled out in full. Use the following style for the references:

Journal

1. Sherman ML, Shafman TD, Kufe DW. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. J Cell Physiol 1988;134:429–436.

Book chapter

2. Gilmore ML, Rouse ST, Heilman CJ, Nash, NR, Levey AI. Receptor fusion proteins and analysis. In: Ariano MA, editor. Receptor localization. New York: Wiley-Liss; 1998. p 75–90.

Book

3. Voet D, Voet JG. Biochemistry: text book for students. New York: John Wiley & Sons, Inc.; 1990. 1223 p.

Tables. Cite each table at the most appropriate point in the text. Tables should present comparisons of data that are too cumbersome to describe in the text, and not merely repeat text information. Each table should be typed double-spaced on a separate sheet of paper and should include a title and, in a footnote, definitions of all abbreviations used in it (even if abbreviations are defined in the text), indicated by the following symbols in this order: *, †, ‡, §, parallel .

Figures. Figures should be good quality and high contrast. High-resolution (300 dpi, laser print) computergraphics will also be accepted. The files should be submitted in either TIF or EPS format. All letters, numbers, and symbols must be large enough that when reduced they will remain at least 2 mm high. Figures not properly prepared will be returned to the contributor for revision. Cite all figures at the most appropriate point in the text. Each figure requires a separate double-spaced legend. Figure legends should briefly describe the information presented; a detailed description of the procedure should appear in Materials and Methods. Abbreviations used in figures and photographs must exactly match those used in the text. Do not submit original artwork or recordings. Color will be printed only at the author's expense. Upon acceptance of color illustrations, the publisher will proide price quotes.

Conventions and Nomenclature are of the style presented in CBE Style Manual: A Guide for Authors, Editors, and Publishers in the Biological Sciences , published by the Council of Biology Editors. The manual is available from the Council of Biology Editors, 9650 Rockville Pike, Bethesda, MD 20814. American spelling will be used throughout as presented in Webster's Ninth New Collegiate Dictionary . For specific nomenclature, the following sources will be consulted: Handbook of Chemistry and Physics and The Merck Index (chemical symbols and formulas), Enzyme Nomenclature (International Union of Biochemistry), Index Bergeyana (bacteria nomenclature), and Biochemical Nomenclature and Related Documents (International Union of Biochemistry).


Note to NIH Grantees. Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate .


Guidelines for Submission
Text

Software and format. Microsoft Word 6.0 is preferred. Please note: This journal does not accept Microsoft WORD 2007 documents at this time. Please use WORD’s “Save As” option to save your document as an older (.doc) file type. Refrain from complex formatting; the Publisher will style your manuscript according to the Journal design specifications. Do not use desktop publishing software such as Aldus PageMaker or Quark XPress. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing program's "fast save" feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor's automated features to create footnotes or reference lists.

File names. Submit the text and tables of each manuscript as individual Word Doc files. Text files should be given the three-letter extension that identifies the file format. Macintosh users should maintain the MS-DOS "eight dot three" file-naming convention.

Illustrations

Resolution. Journal quality reproduction will require grayscale and color files at resolutions yielding approximately 300 dpi. Bitmapped line art should be submitted at resolutions yielding 600-1200 dpi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly. All print reproduction requires files for full color images to be in a CMYK color space. If possible, ICC or ColorSync profiles of your output device should accompany all digital image submissions.

Software and format. All illustration files should be in TIFF or EPS (with preview) formats. Do not submit native application formats. File names. Illustration files should be given the 2- or 3-letter extension that identifies the file format used (i.e., .tif, .eps).”

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.



??? Production Questions ???

MCprod@wiley.com

SEARCH

SEARCH BY CITATION